An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.
CMO-focused marketing and PR agency, ramarketing, has signed a lease on offices in the rapidly growing pharma and biotech hub of Cambridge, Massachusetts.
Quintiles IMS’ Alan Shephard says manufacturing cost transparency will reduce criticism surrounding generics pricing, but one association believes this will lead to anti-competitive behaviour among drugmakers.
CMO PR agency ramarketing has secured investment to set up a US base in a bid to attract North American contractors interested in accessing the complex European market.
Pharma needs to include patient engagement solutions in marketing strategies as the patient’s role in decision-making continues to increase, says UDG COO, following MicroMass acquisition.
The New Zealand Commerce Commission has issued warnings to GlaxoSmithKline and AFT Pharmaceuticals for marketing products which contain the same active ingredients for different indications.
QuintilesIMS is releasing a new pharmaceuticals commercial operations SaaS software called Orchestrated Customer Engagement (OCE) in response to customer demand.
End-to end service offerings are a differentiator within the fragmented CMO industry and not driven by pharma demand, a Results Healthcare report says.
Catalent has more than doubled its biologics business since it went public in 2014, but the sector still represents less than 5% of the CDMO’s revenues.
Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.
A district court judge from California has denied an injunction by Amgen meant to stop the launch of the first biosimilar approved by the US FDA – Sandoz’s Zarxio (filgrastim-sndz).
West says it is one step closer to bringing the Daikyo Crystal Zenith (CZ) drug delivery system to commercialisation with the completion of a first-in-man study.
IPPT has announced plans to buy tablet press maker Kilian for €21m from IMA citing the German firm’s patent portfolio and Asian reach as the key drivers.
J. Knipper and Co. claims the acquisition of InVentiv Health’s sample management and fulfillment business makes it the largest manufacturer-to-physician drug sample services firm in the US.
DKSH says its contract extension with Bayer in Cambodia strengthens its position as a service provider for pharmaceutical companies throughout Southeast Asia.
The US Food and Drug Administration (FDA) has finalized a rule clarifying current good manufacturing practice (cGMP) requirements for single-entity and co-packaged drug-device combination products with few changes to its proposed rule from 2009.
Outsourcing-Pharma.com presents its latest round-up of the latest newcomers and career climbers in the world of pharmaceuticals, including news from AMRI, Ark, and IMC.
The new inVentiv Health Communications Europe (iHCE) base – which officially opened last month – will serve as a marketing and support service hub or ‘super agency’ for the contract services firm’s revamped offering.
Oystar has sold its processing tech units, Huttlin and Manesty, to Bosch in a deal that continues its effort to refocus on primary and secondary packaging.
Applying a business model based on marketing theory to clinical trials can give a consistent framework for planning and managing patient recruitment, say academics.
Cognizant will provide Eli Lilly with end-to-end IT services as part of a multi-year deal to help make Lilly’s US sales and marketing operations more effective, efficient and innovative.
The primary containers and drug delivery system production company, Gerresheimer AG, is further investing in prefilled syringes with the launch of a new production line.
The CDMO Althea Technologies has extended its pre-filled syringe manufacturing capabilities with a new INOVA H3-5 high speed syringe filling line, which will be available for production in Q1 2011.
